Pdb12 Resource Utilization and Economic Cost of Care Based on a Randomized Trial of V.A.C.® Therapy in the Treatment of Diabetic Foot Ulcer Wounds

Apelqvist, Jan; Armstrong, D. G.; Lavery, LA; Boulton, A. J.; Keith,

doi:10.1016/s1098-3015(10)68729-3

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In order to examine this criticism, Apelqvist et al conducted a cost analysis of Armstrong's study patients and found a saving of $12,800 when NPWT was used versus standard care as fewer physician visits and wound care dressings were needed [41]. The NPWT apparatus is easily changed in the outpatient setting, and advances in portability of the unit have improved patient satisfaction and are potentially improving compliance with treatment.…”

Section: Negative Pressure Wound Therapymentioning

confidence: 99%

Delayed wound healing in diabetes: considering future treatments

Dinh¹,

Elder²,

Veves³

2011

Diabetes Management

View full text Add to dashboard Cite

Diabetic foot ulcers result from multiple risk factors including peripheral neuropathy, arterial insufficiency and foot deformities. Recent investigation has also revealed a chronic wound environment with diminished expression of growth factors and cytokines integral to the wound healing process. Current accepted standard of care for the treatment of diabetic foot ulcerations focuses on periodic debridement of the wound, appropriate topical wound therapy, pressure off-loading and treatment of infection. Owing to increased cost and equivocal effectiveness, topical growth factors, bioengineered living skin equivalents, hyperbaric oxygen therapy and negative pressure wound therapy are proposed as adjuncts to standard of care and may be added to the treatment regimen when healing of the wound has stalled. Other future therapies currently under investigation include stem cell therapy, platelet-rich plasma, extracorporeal shock-wave therapy and laser treatment. These modalities continue to be developed and tested, and may offer promise as effective therapies in the future for the chronic diabetic foot ulcer.

show abstract

Section: Negative Pressure Wound Therapymentioning

confidence: 99%

Delayed wound healing in diabetes: considering future treatments

Dinh¹,

Elder²,

Veves³

2011

Diabetes Management

View full text Add to dashboard Cite

show abstract

“…reduction in hospital stay, staff labour and reduction in adverse events) to measure economic benefits. This model has been used for the diabetic foot wound, where there is evidence that VAC therapy is associated with lower overall costs of care (23). Future practice needs to find ways of developing more user‐friendly condition‐specific tools for measuring quality of life and cost‐effectiveness in wound care.…”

Section: Principles Of Best Practicementioning

confidence: 99%

Vacuum Assisted Closure: Recommendations for Use

Apelqvist

Armstrong

Augustin

et al. 2008

International Wound Journal

View full text Add to dashboard Cite

“…CPT codes 97605 and 97606 equate to 0.77 and 0.86 total facility relative value units, respectively. The use of NPWT may reduce long-term costs associated with the use of conventional dressings by improving patient outcomes and requiring fewer dressing changes and less nurse utilization 12,13 ; however, no outcome studies exist in the orthopaedic literature that show a formal cost analysis of NPWT versus controls.…”

mentioning

confidence: 99%